MCMedicalCodingSoftware
C9311

C9311: Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

HCPCSActiveBETOS O1E

C9311 is a HCPCS Level II code for injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered). It belongs to the Outpatient Prospective Payment System section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

The CMS record for C9311

Long descriptor
Injection, eplontersen, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

The official wording. This is what the code means.

Short descriptor
Inj, eplontersen, 1 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2026

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
53: Other

Statute.

Codes adjacent to C9311

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If C9311 is not quite right, the correct code is very often within a few positions of it.

  • C9303Injection, zolbetuximab-clzb, 1 mgterminated
  • C9304Injection, marstacimab-hncq, 0.5 mgterminated
  • C9305Injection, nipocalimab-aahu, 3 mgterminated
  • C9306Injection, telisotuzumab vedotin-tllv, 1 mgterminated
  • C9307Injection, linvoseltamab-gcpt, 1 mgterminated
  • C9308Injection, carboplatin (avyxa), 1 mgterminated
  • C9309Injection, onasemnogene abeparvovec-brve, per treatmentterminated
  • C9310Injection, leucovorin calcium (avyxa), 1 mgterminated
  • C9312Injection, trabectedin (apotex), not therapeutically equivalent to j9362, 0.01 mg
  • C9313Injection, pivekimab sunirine-pvzy, 0.01 mg
  • C9349Puraply, and puraply antimicrobial, any type, per square centimeterterminated
  • C9352Microporous collagen implantable tube (neuragen nerve guide), per centimeter length
  • C9353Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length
  • C9354Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter
  • C9355Collagen nerve cuff (neuromatrix), per 0.5 centimeter length
  • C9356Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter
HCPCS Level II2026Q4-Oct· effective October 1, 2026